TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT03302403

Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: CAR-CD19 T cell
Description: Self-controlled dose escalation and classic 3+3 dose escalation will be applied.

Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: CAR-BCMA T cell
Description: Self-controlled dose escalation and classic 3+3 dose escalation will be applied.

Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: CAR-GPC3 T cell
Description: Self-controlled dose escalation and classic 3+3 dose escalation will be applied.

Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: CAR-CLD18 T cell
Description: Self-controlled dose escalation and classic 3+3 dose escalation will be applied.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: Fludarabine is used for lymphodepletion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Cyclophosphamide is used for lymphodepletion.
Study: NCT01553292

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ECALMIST
Description: Labelled catheter at level of the lips (6 cm plus weight) will inserted through the vocal cords under direct vision using a standard laryngoscope without premedication while maintaining CPAP. 5 ml/kg surfactant syringe will be connected to the catheter hub and 0.25-0.5 ml was administered; then the syringe will be disconnected from the catheter to observe the surfactant moving up and down or coming back as indication of accurate intubation of the trachea. The surfactant the slowly administer by boluses of 0.25-0.5 ml over 20-30 seconds with 10 seconds apart. At the end of the procedure, the operator flushed the catheter with 0.5 ml of air before removing the catheter while maintaining CPAP

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ECALMIST
Description: Vascular catheter of 1.6 French size of 133 mm length 16 gauge used to deliver the BLES; a large volume surfactant while maintain CPAP
Study: NCT03369015

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 10 mg d-amphetamine
Description: 10 mg d-amphetamine dose given (double-blind) and behavioral tasks (EEfRT, PRT, ELT, CGT) administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 10 mg d-amphetamine
Description: 10 mg d-amphetamine dose given (double-blind) and behavioral tasks (EEfRT, PRT, ELT, CGT) administered.
Study: NCT01052259

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Deoxyspergualin
Description: 100mg/vial as active substance; Deoxyspergualin at 3-5 mg/kg/day by 1-3 iv infusion will be given once a day for 5 to 7 days each cycle every month; Total cycle treatment will be 6.
Study: NCT03369015

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 10 mg d-amphetamine
Description: 10 mg d-amphetamine dose given (double-blind) and behavioral tasks (EEfRT, PRT, ELT, CGT) administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 10 mg d-amphetamine
Description: 10 mg d-amphetamine dose given (double-blind) and behavioral tasks (EEfRT, PRT, ELT, CGT) administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 10 mg d-amphetamine
Description: 10 mg d-amphetamine dose given (double-blind) and behavioral tasks (EEfRT, PRT, ELT, CGT) administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 10 mg d-amphetamine
Description: 10 mg d-amphetamine dose given (double-blind) and behavioral tasks (EEfRT, PRT, ELT, CGT) administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 20mg d-amphetamine
Description: 20 mg d-amphetamine dose given (double-blind) and behavioral tasks (EEfRT, PRT, ELT, CGT) administered.
Study: NCT04997213

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Biofeedback exercises
Description: Biofeedback system is a center of pressure-controlled video game-based exercise system designed for patients with neurological and orthopedic diseases and provides balance training using auditory, visual, and pressure biofeedback. The system contains several games, each designed to focus on a different component of balance. Biofeedback is provided by means of a monitor in front of the patient. The balance exercises program was involved a total of 18 sessions, each lasting 20 min, three times a week for six weeks, and was individually tailored based on the patient's tolerance and current motor and sensorial capacities. All patients performed conventional exercises.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Exercises
Description: Classic balance exercises were performed (two-leg stance, semi-tandem stance, tandem stance, standing on one leg, tandem walking, turning completely around, heel-to-toe stance, and standing with the eyes closed). Patients with balance disorder first could be commenced balance training in a seated position before progressing to standing exercises, to the extent that these could be tolerable.
Study: NCT03369015

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 20mg d-amphetamine
Description: 20 mg d-amphetamine dose given (double-blind) and behavioral tasks (EEfRT, PRT, ELT, CGT) administered.
Study: NCT04661852

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cabozantinib
Description: PO (dose and schedule based upon dose level and nomogram)
Study: NCT03369015

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 20mg d-amphetamine
Description: 20 mg d-amphetamine dose given (double-blind) and behavioral tasks (EEfRT, PRT, ELT, CGT) administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 20mg d-amphetamine
Description: 20 mg d-amphetamine dose given (double-blind) and behavioral tasks (EEfRT, PRT, ELT, CGT) administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 20mg d-amphetamine
Description: 20 mg d-amphetamine dose given (double-blind) and behavioral tasks (EEfRT, PRT, ELT, CGT) administered.
Study: NCT05198999

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aquatic-based Plyometric Exercises
Description: The Aqua-PLYO group received the aquatic plyometric exercise training for 45 minutes, three times per week for 12 successive weeks. The training was conducted under close supervision of a licensed pediatric physical therapist according to safety performance guidelines defined by the American Academy of Pediatrics and the US National Strength and Conditioning Association

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard Physical Therapy
Description: The control group received the standard physical rehabilitation program conducted for 45 minutes, thrice a week for 12 consecutive weeks, and consisted of advanced balance training, gait training, postural and flexibility exercises, and strength training exercises.
Study: NCT04661852

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Topotecan
Description: IV, over 30 minutes (schedule based upon dose level)
Study: NCT02179242

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cardiac rehab
Study: NCT03129165

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Screening and prevention of CVD
Description: Drug: Pharmacological control of risk factors in agreement with primary physicians.~Behavioral: Smoking cessation / Control of depression and anxiety / Nutritional counseling / Motivation for physical activity.~Social: Social worker care.
Study: NCT04391647

Intervention type: OTHER
Intervention: First-void urine collection
Description: * One time collection of ca. 20 ml of first-void urine with the Colli-PeeTM device (Novosanis) during visit at the Centre for the Evaluation of Vaccination.~* IF HPV positive and the woman gave consent to be contacted again: Collection of ca. 20 ml of first-void urine with the Colli-PeeTM device (Novosanis) each day during 14 days (n = 14)

Intervention type: OTHER
Intervention: First-void urine collection
Description: * One time collection of ca. 20 ml of first-void urine with the Colli-PeeTM device (Novosanis) during visit at the Centre for the Evaluation of Vaccination.~* IF HPV positive and the woman gave consent to be contacted again: Collection of ca. 20 ml of first-void urine with the Colli-PeeTM device (Novosanis) each day during 14 days (n = 14)

Intervention type: OTHER
Intervention: Blood draw
Description: - One time blood sample collection (5-10 cc) by a study nurse of Centre for the Evaluation of Vaccination.

Intervention type: OTHER
Intervention: Blood draw
Description: - One time blood sample collection (5-10 cc) by a study nurse of Centre for the Evaluation of Vaccination.
Study: NCT04997213

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional Exercises
Description: Classic balance exercises were performed (two-leg stance, semi-tandem stance, tandem stance, standing on one leg, tandem walking, turning completely around, heel-to-toe stance, and standing with the eyes closed). Patients with balance disorder first could be commenced balance training in a seated position before progressing to standing exercises, to the extent that these could be tolerable.
Study: NCT04661852

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: IV, over 30 minutes (schedule based upon dose level)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Myeloid growth factor
Description: subcutaneous filgrastim (daily until ANC ≥ 1,500/mm3 after nadir) or pegfilgrastim (once) must be given, with choice of agent per institutional standard or treating physician preference, starting on day 5, 6, 7 or 8 (depending upon chemotherapy timing)
Study: NCT01708616

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: RO5285119
Description: multiple doses

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RO5285119
Description: multiple doses

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: RO5285119 placebo
Description: multiple doses

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: RO5285119 placebo
Description: multiple doses

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: risperidone
Description: single dose

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: risperidone
Description: single dose

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: risperidone placebo
Description: single dose

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: risperidone placebo
Description: single dose
Study: NCT03299036

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Taiwan ACE Beads with doxorubicin
Description: Similar with commercializing drug-eluting beads, radiologist inject Taiwan ACE Beads with doxorubicin instead of Gelfoam or polyvinyl alcohol.
Study: NCT03432858

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vancomycin
Description: Vancomycin - 1-gram dosing

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cefazolin
Description: 2-gram dosing for patients \<120 kg 3-gram dosing for patients 120 kg or greater

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Saline Solution
Description: Placebo
Study: NCT02351310

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Betamethasone
Description: Course of ACS given intramuscularly (2 doses of 12 mg, 24 hours apart)
Study: NCT02134743

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Implant surgery
Description: Dental implant surgery with two different kinds of implant surface (SLA and modified SLA)

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Implant surgery
Description: Dental implant surgery with two different kinds of implant surface (SLA and modified SLA)
Study: NCT01984203

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Low Load Exercises
Description: All rotator cuff and scapular exercises are performed with 3 sets of 20 repetitions 3 times per week for 12 weeks. The load is set at around 60% of 1 RM (20 reps).~The glenohumeral/postural corrective exercises are performed with 3 sets of 5 repetitions (The position is held for 15 seconds per repetition).

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Progressive Heavy Strength Exercises
Description: All scapular exercises are performed with 3 sets of 20 repetitions 3 times per week for 12 weeks. The load is set at around 60% of 1 RM (20 reps).~The rotator cuff exercises are performed with 4 sets of gradually progressive loading and decreasing the repetitions performed in each set.~Week 1: 15reps (70% 1RM) Week 2-3: 12 reps (75% 1RM) Week 4-5: 10 reps (80% 1RM) Week 6-8: 8 reps (85% 1RM) Week 9-12: 6 reps (90% 1RM)~The glenohumeral/postural corrective exercises are performed with 3 sets of 5 repetitions (The position is held for 15 seconds per repetition).
Study: NCT03838861

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: NEMO: NEw MOdel of follow-up
Description: The nurse led model is built upon phone contacts with content and intervals individually planned by the nurse and the patient. The individual contacts will be supported by graphic visualisation of ePROMs in REDCap filled out by the patient before each contact including DGCG's disease specific symptom list and the generic European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) (24) supplemented with the relevant disease-specific add-on module (25, 26). The sum scores are visualised with colours to indicate severe problems (red), no problems (green) and mild or moderate problems (yellow and orange), respectively. Hence, alarm symptoms and problem areas are clearly presented to the project nurse and changes can be visualised over time enhancing the interpretation. The patient will be given access to own scoring results to obtain an understanding of the meaning of changes in health status.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: NEMO: NEw MOdel of follow-up
Description: The nurse led model is built upon phone contacts with content and intervals individually planned by the nurse and the patient. The individual contacts will be supported by graphic visualisation of ePROMs in REDCap filled out by the patient before each contact including DGCG's disease specific symptom list and the generic European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) (24) supplemented with the relevant disease-specific add-on module (25, 26). The sum scores are visualised with colours to indicate severe problems (red), no problems (green) and mild or moderate problems (yellow and orange), respectively. Hence, alarm symptoms and problem areas are clearly presented to the project nurse and changes can be visualised over time enhancing the interpretation. The patient will be given access to own scoring results to obtain an understanding of the meaning of changes in health status.
Study: NCT02430779

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: rreversible electroporation (IRE)
Description: Irreversible Electroportion For Unresectable Renal Pelvic and Ureteral Neoplasms guide with ultrasound or/and CT.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NanoKnife
Study: NCT01321463

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PH-797804
Description: 6 mg oral tablet once daily for 12 weeks

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo oral tablet once daily for 12 weeks
Study: NCT00045903

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exposure and Ritual Prevention (Cognitive Behavioral Therapy)

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Stress Management Therapy (Cognitive Behavior Therapy)
Study: NCT02743234

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplantation
Description: FMT follows 4-10 days of vancomycin 125 mg x 4 daily
Study: NCT03810378

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mediterranean Diet (Med-Plus)
Description: Participants will follow the Med-Plus diet for 12 weeks, then switch to the alternate diet for another 12 weeks (no washout period).

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Well-Formulated Ketogenic Diet (WFKD)
Description: Participants will follow the WFKD diet for 12 weeks, then switch to the alternate diet for another 12 weeks (no washout period).
Study: NCT03029676

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: benzodiazepines
Description: sedative

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: opioid
Description: analgetic, sedative

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: opioid
Description: analgetic, sedative

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: spinal anesthesia
Study: NCT03369015

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo dose given (double-blind) and behavioral tasks (EEfRT, PRT, ELT, CGT) administered.
Study: NCT03029676

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: spinal anesthesia
Study: NCT01988597

Intervention type: OTHER
Intervention: Dry eyes
Study: NCT00706394

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Endologix Powerlink 34 mm stent graft cuff
Description: Endovascular abdominal aortic aneurysm repair
Study: NCT04432740

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conservative Treatment of Distal Radius Fracture
Description: The purpose of this prospective randomized study was to compare a new reverse sugar tong splint technique that does not immobilize the elbow with a below-arm cast, in terms of patient radiological and clinical outcomes and the ability to maintain fracture reduction.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conservative Treatment of Distal Radius Fracture
Description: The purpose of this prospective randomized study was to compare a new reverse sugar tong splint technique that does not immobilize the elbow with a below-arm cast, in terms of patient radiological and clinical outcomes and the ability to maintain fracture reduction.
Study: NCT00430898

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Basiliximab
Description: 3 doses of 40mg, IV at baseline, week 2, and week 4

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Basiliximab
Description: 3 doses of 40mg, IV at baseline, week 2, and week 4
Study: NCT02925312

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Diabetes Pathway
Description: Medication algorithm, survival skills education, enhanced patient-provider communication facilitated by near, real-time blood glucose monitoring
Study: NCT04724681

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: WARD CSS
Description: Wireless devices monitor vital signs continuously and transmit real-time data to an app that notifies clinical personnel when relevant deviations in vital signs occur This group will be monitored with standard Early Warning Score as well
Study: NCT03091699

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nicotine
Description: Participants will be required to smoke a cigarette to completion in a 20 minute time frame.
Study: NCT02743234

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fidaxomicin
Description: Fidaxomicin 200 mg x 2 daily for 10 days

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vancomycin
Description: Vancomycin 125 mg x 4 daily for 10 days
Study: NCT03091699

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Moderate Intensity Exercise
Description: Participants will be required to perform 20 minutes of acute moderate intensity exercise (brisk walk) on a treadmill.
Study: NCT02381548

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adavosertib
Description: Given PO

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Belinostat
Description: Given IV

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pharmacological Study
Description: Correlative studies
Study: NCT01171287

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Driving with an Aircast Walker

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Driving with a walking cast

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Driving with a running shoe
Study: NCT04231513

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: E2814
Description: E2814, intravenous infusion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: E2814
Description: E2814, intravenous infusion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: E2814
Description: E2814, intravenous infusion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: E2814
Description: E2814, intravenous infusion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: E2814
Description: E2814, intravenous infusion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: E2814
Description: E2814, intravenous infusion.
Study: NCT03369015

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo dose given (double-blind) and behavioral tasks (EEfRT, PRT, ELT, CGT) administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo dose given (double-blind) and behavioral tasks (EEfRT, PRT, ELT, CGT) administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo dose given (double-blind) and behavioral tasks (EEfRT, PRT, ELT, CGT) administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo dose given (double-blind) and behavioral tasks (EEfRT, PRT, ELT, CGT) administered.
Study: NCT04231513

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: E2814
Description: E2814, intravenous infusion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: E2814
Description: E2814, intravenous infusion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: E2814
Description: E2814, intravenous infusion.
Study: NCT01722344

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Individual Placement and support (IPS)
Description: IPS involves an employment specialist who is integrated within the mental health team, and carries out all phases of the vocational services, with a caseload on less than 25. The intervention is based on the 7 principles of IPS Supported Employment. The essence of these principles is an individualized and rapid search for competitive employment or education that avoids prolonged prevocational training and preparation. The intervention is integrated within the mental health services, with emphasis on client preference and choice regarding jobs, and with availability of on going job support and benefit counselling

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Individual Placement and support (IPS)
Description: IPS involves an employment specialist who is integrated within the mental health team, and carries out all phases of the vocational services, with a caseload on less than 25. The intervention is based on the 7 principles of IPS Supported Employment. The essence of these principles is an individualized and rapid search for competitive employment or education that avoids prolonged prevocational training and preparation. The intervention is integrated within the mental health services, with emphasis on client preference and choice regarding jobs, and with availability of on going job support and benefit counselling